NATIONAL TUBEROUS SCLEROSIS ASSOCIATION INC: Form 990, tax year 2024

View the entire original 990 at ProPublica ↗

Organization
NATIONAL TUBEROUS SCLEROSIS ASSOCIATION INC (EIN 95-3018799)
Tax period
2024-01-01 to 2024-12-31
Filed
2025-04-11
IRS object ID
202531019349300508
Schema version
2024v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2025-04-11T08:26:26-05:00ReturnTs
Tax Period End2024-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN470900880PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CALIBRE CPA GROUP PLLCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line17501 WISCONSIN AVENUE SUITE 1200AddressLine1Txt
Address Line2WESTAddressLine2Txt
CityBETHESDACityNm
State AbbreviationMDStateAbbreviationCd
ZIP20814ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2024-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN953018799EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1NATIONAL TUBEROUS SCLEROSISBusinessNameLine1Txt
Business Name Line2ASSOCIATIONBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlNATIBusinessNameControlTxt
Phone3015629890PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line18737 COLESVILLE ROAD 400AddressLine1Txt
CitySILVER SPRINGCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonKARI L ROSBECKPersonNm
Person TitlePRESIDENT & CEOPersonTitleTxt
Phone3015629890PhoneNum
Signature2025-04-11SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd
FieldValueIRS element (for citing)
IRS Responsible Prty Info CurrYes (1)IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonERIN CRANMERPreparerPersonNm
PTINP01712644PTIN
Phone2023319880PhoneNum
Preparation2025-04-11PreparationDt
FieldValueIRS element (for citing)
Tax2024TaxYr
Build TS2025-03-06 01:10:19ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Address ChangeYes (X)AddressChangeInd

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1TSC ALLIANCEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerKARI L ROSBECKPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line18737 COLESVILLE ROAD 400AddressLine1Txt
CitySILVER SPRINGCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$12,010,053GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.TSCALLIANCE.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1975FormationYr
Legal Domicile StateCALegalDomicileStateCd
Activity Or MissionTO IMPROVE QUALITY OF LIFE FOR EVERYONE AFFECTED BY TUBEROUS SCLEROSIS COMPLEX BY CATALYZING NEW TREATMENTS, DRIVING RESEARCH TOWARD A CURE AND EXPANDING ACCESS TO LIFELONG SUPPORT.ActivityOrMissionDesc
Voting Members Governing Body27VotingMembersGoverningBodyCnt
Voting Members Independent27VotingMembersIndependentCnt
Total Employee26TotalEmployeeCnt
Total Volunteers373TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$6,747,948PYContributionsGrantsAmt
CY Contributions Grants$7,048,334CYContributionsGrantsAmt
PY Program Service Revenue$2,815,353PYProgramServiceRevenueAmt
CY Program Service Revenue$2,105,029CYProgramServiceRevenueAmt
PY Investment Income$36,732PYInvestmentIncomeAmt
CY Investment Income$52,809CYInvestmentIncomeAmt
PY Other Revenue$416,350PYOtherRevenueAmt
CY Other Revenue$794,723CYOtherRevenueAmt
PY Total Revenue$10,016,383PYTotalRevenueAmt
CY Total Revenue$10,000,895CYTotalRevenueAmt
PY Grants And Similar Paid$845,292PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$730,927CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$3,024,376PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$3,153,884CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$1,348,202CYTotalFundraisingExpenseAmt
PY Other Expenses$4,597,980PYOtherExpensesAmt
CY Other Expenses$4,775,207CYOtherExpensesAmt
PY Total Expenses$8,467,648PYTotalExpensesAmt
CY Total Expenses$8,660,018CYTotalExpensesAmt
PY Revenues Less Expenses$1,548,735PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$1,340,877CYRevenuesLessExpensesAmt
Total Assets BOY$16,085,768TotalAssetsBOYAmt
Total Assets EOY$17,254,701TotalAssetsEOYAmt
Total Liabilities BOY$2,088,420TotalLiabilitiesBOYAmt
Total Liabilities EOY$1,888,588TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$13,997,348NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$15,366,113NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTO IMPROVE QUALITY OF LIFE FOR EVERYONE AFFECTED BY TUBEROUS SCLEROSIS COMPLEX BY CATALYZING NEW TREATMENTS, DRIVING RESEARCH TOWARD A CURE AND EXPANDING ACCESS TO LIFELONG SUPPORT.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$4,810,946ExpenseAmt
Grant$725,619GrantAmt
Revenue$2,098,994RevenueAmt
DescRESEARCH PROGRAM STIMULATES AND SUPPORTS BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH ON THE VARIOUS MANIFESTATIONS OF TUBEROUS SCLEROSIS COMPLEX (TSC) TO FURTHER THE DEVELOPMENT OF CLINICAL THERAPIES AND, ULTIMATELY, A CURE FOR TSC. DIRECTED BY STEVEN L. ROBERDS, PHD, CHIEF SCIENTIFIC OFFICER, THE TSC ALLIANCE RESEARCH PROGRAM BUILDS AND FOSTERS COLLABORATIONS BETWEEN BASIC AND CLINICAL RESEARCHERS BY COLLECTING AND DISTRIBUTING TSC NATURAL HISTORY DATA AND BIOSAMPLES, THROUGH COLLABORATIVE PRECLINICAL AND CLINICAL RESEARCH PROGRAMS, AND BY HOSTING BIENNIAL INTERNATIONAL TSC RESEARCH CONFERENCES.SINCE 1984, THE TSC ALLIANCE HAS INVESTED MORE THAN $39 MILLION INTO TSC RESEARCH PROJECTS THROUGH GRANTS AND CONTRACTS: $20.9 MILLION IN RESEARCH GRANTS AND POSTDOCTORAL FELLOWSHIPS, $5.5 MILLION INTO THE NATURAL HISTORY DATABASE AND BIOSAMPLE REPOSITORY, $11.6 MILLION INTO THE PRECLINICAL CONSORTIUM, AND $1.8 MILLION INTO THE CLINICAL RESEARCH CONSORTIUM. GRANT AND FELLOWSHIP APPLICATIONS ARE REVIEWED IN A THREE-STEP PROCESS: (1) ALL APPLICATIONS ARE REVIEWED BY A COMMITTEE COMPRISED OF SCIENTISTS KNOWLEDGEABLE ABOUT THE TOPIC AREA FOR SCIENTIFIC MERIT AND OF CAREGIVERS OR ADULTS AFFECTED BY TSC FOR POTENTIAL IMPACT ON THE LIVES OF THOSE AFFECTED BY TSC; (2) THE SCIENCE AND MEDICAL COMMITTEE OF THE BOARD OF DIRECTORS EVALUATES THE GRANT REVIEW COMMITTEE'S RECOMMENDATIONS AND THE RELEVANCE OF THE APPLICATIONS TO THE TSC ALLIANCE'S FUNDING PRIORITIES; AND (3) THE BOARD OF DIRECTORS THEN REVIEWS THE RECOMMENDATIONS OF THE SCIENCE AND MEDICAL COMMITTEE AND MAKES FINAL APPROVAL FOR FUNDING. FOR A COMPLETE LIST OF CURRENTLY FUNDED PROJECTS AND AN ARCHIVE OF PAST AWARDEES, PLEASE VISIT TSCALLIANCE.ORG/RESEARCHERS/GRANTS-FUNDING/.IMPLEMENTED IN 2006, THE TSC NATURAL HISTORY DATABASE (NHD) CAPTURES CLINICAL DATA TO DOCUMENT THE IMPACT OF THE DISEASE ON A PERSON'S HEALTH OVER HIS/HER LIFETIME. THE DATABASE SERVES AS A RESOURCE OF INFORMATION THAT HELPS TSC RESEARCHERS BETTER UNDERSTAND THE PROGRESSION OF THE DISEASE, DESIGN HYPOTHESIS-DRIVEN QUESTIONS TO HASTEN THE DISCOVERY OF NEW TREATMENTS AND IDENTIFY PERSONS WITH TSC WHO ARE ELIGIBLE TO PARTICIPATE IN RESEARCH STUDIES. AS OF DECEMBER 2024, THE NATURAL HISTORY DATABASE CONTAINED 2,780 PARTICIPANTS ENROLLED IN THE PROJECT FROM AMONG 22 TSC CLINIC SITES AND THROUGH THE TSC ALLIANCE. THE TSC ALLIANCE PROVIDES FUNDING TO PARTICIPATING CLINICS TO PERFORM DATA ENTRY, MONITORS THE INTEGRITY OF THE DATABASE, AND MAKES DATA AVAILABLE TO INVESTIGATORS TO ANSWER SPECIFIC RESEARCH QUESTIONS AND IDENTIFY POTENTIAL PARTICIPANTS FOR CLINICAL TRIALS AND STUDIES BUILDING UPON THE NATURAL HISTORY DATABASE, THE TSC BIOSAMPLE REPOSITORY IS A TSC ALLIANCE-DIRECTED PROJECT INITIATED IN 2014 THAT WILL IMPACT RESEARCH FOR DECADES TO COME. THE TSC ALLIANCE'S SCIENCE AND MEDICAL COMMITTEE IDENTIFIED THIS AS A GAP THAT CAN ONLY BE FILLED EFFECTIVELY WITH LEADERSHIP OF THE TSC ALLIANCE, GUIDED BY A STEERING COMMITTEE OF CLINICIANS AND RESEARCHERS. HIGH-QUALITY BIOSAMPLES SUCH AS BLOOD, DNA, AND TISSUES LINKED TO DETAILED CLINICAL DATA ARE CRITICAL FOR RESEARCHERS TO UNDERSTAND WHY TSC IS SO DIFFERENT FROM PERSON TO PERSON. SAMPLES IN THE REPOSITORY ARE LINKED TO DETAILED CLINICAL DATA IN OUR EXISTING TSC NATURAL HISTORY DATABASE AND ARE AVAILABLE TO QUALIFIED RESEARCHERS WORLDWIDE. SAMPLES ARE HOUSED AT AND DISTRIBUTED FROM THE VAN ANDEL INSTITUTE IN GRAND RAPIDS, MI, UNDER CONTROL OF THE TSC ALLIANCE. AS OF DECEMBER 2024, THE BIOSAMPLE REPOSITORY HAS ACQUIRED 2,917 BLOOD, BUCCAL (CHEEK) SWAB, OR TISSUE SAMPLES. SINCE INCEPTION, 3,370 PORTIONS OF SAMPLES HAVE BEEN DISTRIBUTED TO 50 DISTINCT RESEARCHERS FOR 59 DISTINCT PROJECTS.THE ORGANIZATION CONTINUES TO GROW THE BIOSAMPLE REPOSITORY BY COLLECTING BLOOD SAMPLES ANNUALLY FROM PARTICIPANTS WHO VOLUNTEER TO DO SO, ENABLING RESEARCHERS TO STUDY CHANGES IN PROTEINS AND OTHER MOLECULES IN THE BLOOD OVER TIME; ADDING ADDITIONAL TSC CLINICS AS PARTICIPATING BIOSAMPLE REPOSITORY COLLECTION SITES; AND COLLECTING BLOOD USING MOBILE PHLEBOTOMY, ENABLING PEOPLE TO DONATE SAMPLES REGARDLESS OF WHERE THEY LIVE IN THE US AND WHETHER THEY ARE SEEN AT A TSC CLINIC. SINCE THE INCEPTION OF OUR MOBILE PHLEBOTOMY INITIATIVE, WE HAVE ACQUIRED 557 BLOOD SAMPLES VIA MOBILE PHLEBOTOMY. TO ENCOURAGE AND ENABLE MORE RESEARCHERS TO UTILIZE BIOSAMPLES, THE TSC ALLIANCE AWARDED THREE SEED GRANTS IN 2024, TOTALING $43,625, TO LABS THAT SUBMITTED MERITORIOUS AND INNOVATIVE IDEAS FOR RESEARCH ON TSC BIOSAMPLES.THE TSC ALLIANCE'S WHOLE-GENOME SEQUENCING (WGS) INITIATIVE USING DNA FROM BLOOD SAMPLES IN OUR BIOSAMPLE REPOSITORY SEQUENCED AN ADDITIONAL 131 SAMPLES IN 2024, TOTALING 242 SAMPLES SINCE INCEPTION. THIS INITIATIVE SUPPORTS CLINICAL VALIDATION OF VARIANTS FOUND VIA WGS IN EITHER THE TSC1 OR TSC2 GENE, AND GENETIC RESULTS ARE OFFERED BACK TO PARTICIPANTS ALONG WITH A GENETIC COUNSELING SESSION FREE OF CHARGE TO THE FAMILY TO HELP THEM BETTER UNDERSTAND THEIR UNIQUE TSC DIAGNOSIS AND PROVIDE VALUABLE INFORMATION FOR FUTURE DECISION MAKING SUCH AS FAMILY PLANNING.IN DECEMBER 2021, THE TSC ALLIANCE ADDED THE TSC SELF-REPORT PORTAL TO THE TSC NATURAL HISTORY DATABASE. THIS PORTAL PERMITS THE COLLECTION OF PATIENT-REPORTED OUTCOMES ON HOW TSC AFFECTS INDIVIDUALS AND FAMILIES, WHICH WILL COMPLEMENT MEDICAL DATA IN THE NATURAL HISTORY DATABASE. THE PURPOSE OF THIS INITIATIVE IS TO HELP THE TSC ALLIANCE AND TSC RESEARCHERS BETTER UNDERSTAND THE PERSPECTIVE OF THOSE AFFECTED BY TSC TO DEVELOP TOOLS TO MEASURE IMPROVEMENT IN AREAS MOST IMPORTANT TO THE TSC COMMUNITY. EVENTUALLY, THESE MEASUREMENTS CAN BE USED TO IDENTIFY ENDPOINTS FOR CLINICAL TRIALS AND EVIDENCE-BASED GUIDELINES FOR TREATMENT.ONE OF THE MOST IMPACTFUL ASPECTS OF TSC ON THE QUALITY OF LIFE FOR PEOPLE LIVING WITH TSC IS TSC-ASSOCIATED NEUROPSYCHIATRIC DISORDERS (TAND). THEREFORE, THE TSC ALLIANCE'S FIRST USE OF THE PORTAL IS THROUGH COLLABORATION WITH THE TANDEM PROJECT (EMPOWERING FAMILIES THROUGH TECHNOLOGY: A MOBILE-HEALTH PROJECT TO REDUCE THE TAND IDENTIFICATION AND TREATMENT GAP) BY ALLOWING THE COMMUNITY TO COMPLETE THE SELF-QUANTIFIED TAND CHECKLIST (TAND-SQ). AT THE END OF 2024, 83 INDIVIDUALS HAD COMPLETED THE TAND-SQ THROUGH THE SELF-REPORT PORTAL.THE TSC ALLIANCE LAUNCHED THE TSC PRECLINICAL CONSORTIUM IN 2015 TO HELP ADVANCE MORE DRUG CANDIDATES INTO CLINICAL TESTING. TO ACHIEVE THIS END, THE PRECLINICAL CONSORTIUM PROVIDES THE INFRASTRUCTURE TO FOSTER COLLABORATION BETWEEN ACADEMIA AND PHARMACEUTICAL INDUSTRY RESEARCHERS AND FOR ACCESS TO RESOURCES DESIGNED TO HELP FACILITATE DRUG DEVELOPMENT IN TSC. COLLABORATING WITH THE TSC COMMUNITY, THE CONSORTIUM HAS IDENTIFIED AND IMPLEMENTED ROBUST AND REPRODUCIBLE CELL AND ANIMAL MODELS FOR TSC MANIFESTATIONS INCLUDING TUMORS, EPILEPSY, AND TAND. IN 2022, THE TSC ALLIANCE ENTERED INTO A PARTNERSHIP WITH THE LAM FOUNDATION TO ADD LAM MOUSE MODELS TO THE PRECLINICAL CONSORTIUM. THE TSC ALLIANCE HAS LICENSES TO USE SPECIFIC TSC MOUSE MODELS FOR EXPERIMENTS CARRIED OUT BY THE PRECLINICAL CONSORTIUM, AND ALL MOUSE LICENSE AGREEMENTS INCLUDE THE RIGHTS FOR THE TSC ALLIANCE TO PERFORM EXPERIMENTS UNDER CONTRACT FOR COMMERCIAL ENTITIES. THIS ENSURES DATA GENERATED BY THE PRECLINICAL CONSORTIUM CAN BE USED TO ACCELERATE THE DEVELOPMENT OF NEW TREATMENTS BY COMMERCIAL ENTITIES AS WELL AS ACADEMIC INVESTIGATORS. EXPERIMENTS ARE EXECUTED AT PARTNERING RESEARCH INSTITUTIONS TO ENSURE CONSISTENCY IN TESTING, DATA ACQUISITION AND INTERPRETATION. EPILEPSY STUDIES ARE CONDUCTED AT PSYCHOGENICS (US), AND THE TUMOR GRAFT MODEL AND CELL-BASED ASSAYS ARE CONDUCTED AT PORSOLT (FRANCE). THE VAN ANDEL RESEARCH INSTITUTE, A NON-PROFIT RESEARCH ORGANIZATION, MAINTAINS A COLONY OF TSC2+/- AJ MICE AND F L7-CRE-TSC2 MICE ON BEHALF OF THE PRECLINICAL CONSORTIUM. THE PRECLINICAL CONSORTIUM INVITES COMPOUND NOMINATIONS FROM ACADEMIC AND INDUSTRY RESEARCHERS TO CONTINUE TO REFRESH OUR PIPELINE BASED ON THE LATEST DATA AND NOVEL IDEAS. THE NOMINATIONS ARE PEER REVIEWED BY CONSORTIUM MEMBERS AND PRIORITIZED BY THE PRECLINICAL CONSORTIUM STEERING COMMITTEE FOR FUNDING BY THE TSC ALLIANCE. IF THE TSC ALLIANCE FUNDS THE STUDY, THE DATA ARE SHARED WITH THE CONSORTIUM FOR TRANSPARENCY AND STIMULATION OF ADDITIONAL HYPOTHESES. A MEMBERS MEETING IS HELD ANNUALLY TO KEEP MEMBERS ENGAGED AND ALIGNED ON THE CONSORTIUM'S STRATEGY AND PRIORITIES. PARTNERSHIP WITH PHARMACEUTICAL COMPANIES IS AN IMPORTANT ASPECT OF THE CONSORTIUM, AS THESE ORGANIZATIONS HAVE THE INFRASTRUCTURE TO EFFICIENTLY MOVE PRECLINICAL RESEARCH FINDINGS TO CLINICAL TESTING AND EVENTUALLY COMMERCIAL DISTRIBUTION. THE PRECLINICAL CONSORTIUM ENDED 2024 WITH 10 ACTIVE INDUSTRY PARTNERS, INCREASING THE TOTAL NUMBER TO 24 INDUSTRY PARTNERS SINCE 2016.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$1,034,068ExpenseAmt
DescSUPPORT SERVICES. SEE SCHEDULE O FOR FULL PROGRAM DESCRIPTION.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$478,028ExpenseAmt
DescPUBLIC HEALTH. SEE SCHEDULE O FOR FULL PROGRAM DESCRIPTION.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

FieldValueIRS element (for citing)
Expense$391,662ExpenseAmt
Grant$5,308GrantAmt
DescGOVERNMENT RELATIONS EFFORTS FOCUS ON INCREASING FEDERAL AND STATE APPROPRIATIONS FOR TSC RESEARCH, RAISING AWARENESS, AND COLLABORATING WITH GOVERNMENT PARTNERS TO DRIVE TSC RESEARCH FORWARD AND IMPROVE CLINICAL CARE AND TREATMENT OPTIONS FOR INDIVIDUALS WITH TSC. ON THE STATE LEVEL, THE TSC ALLIANCE ADVOCATED FOR STATE FUNDING FOR TSC CENTERS IN ALABAMA, MISSOURI, AND MARYLAND, RESULTING IN AT LEAST $1.275 MILLION IN STATE APPROPRIATIONS. THE 2024 MARCH ON CAPITOL HILL WAS HELD FEBRUARY 28 WITH CONGRESSIONAL MEETINGS TAKING PLACE THROUGH MID-MARCH. MORE THAN 130 PEOPLE PARTICIPATED IN OVER 367 IN-PERSON AND VIRTUAL MEETINGS. OUR HOUSE DEAR COLLEAGUE LETTER FOR FY25 WAS CO-SPONSORED BY REPRESENTATIVES FITZPATRICK (R-PA) AND RASKIN (D-MD) AND CLOSED WITH 185 SIGNERS. THE SENATE DEAR COLLEAGUE LETTER WAS CO-SPONSORED BY SENATORS CRAMER (R-ND) AND HEINRICH (D-NM) AND CLOSED WITH 41 SIGNERS.TOTAL FUNDING FOR THE TSCRP HAS BEEN $121 MILLION SINCE 2002, INCLUDING A $8 MILLION APPROPRIATION FOR FY24. RESEARCH PERFORMED THROUGH THIS PROGRAM HAS RECENTLY LED TO ADDITIONAL CLINICAL TRIALS INCLUDING DETERMINING IF IMATINIB, A DRUG FDA-APPROVED FOR CANCER, CAN SAFELY IMPROVE LEVELS OF VEGF-D, A BIOMARKER OF LYMPHANGIOLEIOMYOMATOSIS (LAM), A LIFE-THREATENING LUNG MANIFESTATION OF TSC, FUNDED IN FY2013; TWO TSCRP AWARDS IN FY2012 AND FY2015 THAT ENABLED GENERATION OF A POTENTIAL APPROACH FOR GENE THERAPY OF TSC, WHICH HAS SHOWN PROMISING RESULTS IN A MOUSE MODEL OF TSC TUMORS IN THE BRAIN; A MULTI-SITE CLINICAL TRIAL TESTING THE EFFICACY OF AN EXPERIMENTAL TOPICAL RAPAMYCIN CREAM TO TREAT THE DISFIGURING FACIAL TUMORS, CALLED FACIAL ANGIOFIBROMAS, CAUSED BY TSC FUNDED IN FY2010 THAT LED THE THIRD FDA-APPROVED DRUG TO TREAT TSC IN APRIL 2022; AND A CLINICAL RESEARCH NETWORK THAT WAS CREATED TO TEST POTENTIAL NEW THERAPIES, TO VALIDATE BIOMARKERS, AND TO LEARN THE NATURAL HISTORY OF LEADING TO A CLINICAL TRIAL FUNDED IN FY2012. DATA OBTAINED FROM AN FY2010 TSCRP CLINICAL RESEARCH AWARD TO DEFINE EARLY AUTISM PREDICTORS IN TSC AND AN FY2014 TSCRP AWARD FOR A PILOT CLINICAL TRIAL IS BEING TESTED IN A LARGE, NIH-FUNDED CLINICAL TRIAL LOOKING AT THE EFFECTIVENESS OF A BEHAVIORAL INTERVENTION STRATEGY, JASPER, TO IMPROVE OUTCOMES IN CHILDREN WITH AUTISM. THE TSCRP HAS ALSO FUNDED RESEARCH TO DEVELOP ANIMAL MODELS OF TSC THAT HAVE SEIZURES, ENABLING A BETTER UNDERSTANDING OF THE ETIOLOGY OF TSC. BASED ON DATA FROM TSCRP-FUNDED ANIMAL MODELS OF TSC THAT HAVE SEIZURES AND SHARE PATHOLOGY RELATED TO THAT OF TRAUMATIC BRAIN INJURY, AN INDUSTRY-SPONSORED CLINICAL TRIAL DEMONSTRATED THE EFFECTIVENESS THE MTOR INHIBITOR, EVEROLIMUS, AT TREATING EPILEPSY IN MANY INDIVIDUALS WITH TSC. NONE OF THIS PROGRESS WOULD HAVE BEEN POSSIBLE WITHOUT THE CRITICAL SUPPORT PROVIDED THROUGH THE TSCRP.GLOBAL OUTREACH WORKS TO ADDRESS UNMET NEEDS WITHIN THE GLOBAL TSC COMMUNITY. THE PROGRAM PROVIDES THE OPPORTUNITY FOR THE TSC ALLIANCE TO SHARE EXPERIENCES AND ASSIST IN THE START-UP OF SUPPORT OF TSC-RELATED ORGANIZATIONS IN OTHER COUNTRIES. A GLOBAL ALLIANCE IS A STRUCTURED GROUP OF EMPOWERED AND CARING VOLUNTEERS WHO WORK CLOSELY WITH THE TSC ALLIANCE TO FACILITATE LOCAL CONNECTIONS FOR INDIVIDUALS AND FAMILIES AFFECTED BY TSC AND RAISE REVENUE AND AWARENESS WHILE SUPPORTING THE MISSION OF THE ORGANIZATION. THE TSC ALLIANCE HAS FIVE GLOBAL PARTNERSHIPS, INCLUDING TSC ALLIANCE OF ISRAEL, TS CANADA ST, TSC ALLIANCE OF MEXICO, HUNGARIAN FOUNDATION FOR TUBEROUS SCLEROSIS, AND TSC ALLIANCE OF INDIA. THE TSC ALLIANCE RECOGNIZES 14 TSC CLINICS IN GLOBAL ALLIANCE COUNTRIES. PROFESSIONAL EDUCATION EXPANDS PROGRAMS TO TARGET RESEARCHERS AND HEALTHCARE PROVIDERS CARING FOR INDIVIDUALS WITH TSC, MEDICAL STUDENTS, GENETIC COUNSELORS AND EDUCATORS TO MINIMIZE THE CONSEQUENCES OF IGNORANCE AND MISINFORMATION. THE TSC ALLIANCE EXHIBITED AT THE AMERICAN EPILEPSY SOCIETY ANNUAL MEETING. STAFF MEMBERS AND A VOLUNTEER SHARED EDUCATIONAL MATERIALS WITH ATTENDEES WHO VISITED THE BOOTH, AND STAFF PRESENTED DATA AT A POSTER SESSION, ATTENDED SCIENTIFIC SESSIONS, AND HELD MANY MEETINGS WITH ACADEMIC AND INDUSTRY PARTNERS. STAFF ALSO PARTICIPATED IN THE TSC SPECIAL INTEREST GROUP SESSION, AND THE TSC ALLIANCE HOSTED MORE THAN 100 PEOPLE AT A RECEPTION WHICH INCLUDED A VIDEO PRESENTATION OF HOW PEOPLE'S LIVES HAVE BEEN IMPACTED BY TSC, HOW RESEARCH HAS MADE TREMENDOUS IMPACT, AND HOW MUCH IS LEFT TO BE DONE TO CURE, OR FULLY TREAT, TSC.THE TSC ALLIANCE PARTICIPATED IN OR PRESENTED AT 24 PROFESSIONAL MEETINGS IN 2024 INCLUDING RESEARCH AMERICA ANNUAL ADVOCACY AWARDS, AMGEN FUTURE OF UCDS ADVISORY BOARD MEETING, ATS CORPORATE ADVISORY BOARD MEETING, BOSTON CHILDREN'S HOSPITAL TRANSLATIONAL RESEARCH SYMPOSIUM, EAN CONGRESSIONAL BRIEFING, INTERAGENCY COLLABORATIVE TO ADVANCE RESEARCH IN EPILEPSY (ICARE), HEALTH RESEARCH ALLIANCE: CONVENING ON BULLYING AND HARASSMENT FORUM, INFANTILE SPASMS ACTION NETWORK GOVERNANCE MEETING, BRIDGEBIO TOWN HALL, TANDEM MINI SYMPOSIUM, MNK ADVISORY BOARD MEETING, NINDS NONPROFIT FORUM, RARE DISEASE DIVERSITY COALITION, TSCI WORKSHOP, TAND CONSORTIUM, TSC REPRODUCTIVE & PERINATAL TASK FORCE WORKSHOP, CPATH GLOBAL IMPACT CONFERENCE, GLOBAL GENES RARE SUMMIT, BOSTON CHILDREN'S HOSPITAL TRANSLATIONAL RESEARCH SYMPOSIUM, PCORI ANNUAL MEETING, RDCRN FALL MEETING, AES, AND THE MILKEN INSTITUTE FUTURE OF HEALTH SUMMIT.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$391,662TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$5,308TotalOtherProgSrvcGrantAmt
Total Program Service Expenses$6,714,704TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (1)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other AssetsYes (1)ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document35IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee26EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo ContributionsYes (1)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (1)QuidProQuoContriDisclInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members27GoverningBodyVotingMembersCnt
Independent Voting Member27IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or StockholdersYes (1)MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local ChaptersYes (1)LocalChaptersInd
Policies Reference ChaptersYes (1)PoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldINStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1TSC ALLIANCEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone3015629890PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line18737 COLESVILLE ROAD 400AddressLine1Txt
CitySILVER SPRINGCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (33 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
WILLIAM JOSEPH
BOARD CHAIR5.00Yes (X)Yes (X)$0$0$0
PAUL WAXLAX
VICE CHAIR5.00Yes (X)Yes (X)$0$0$01.00
BRITTANY SMITH
TREASURER5.00Yes (X)Yes (X)$0$0$01.00
LESLEY HOLMES
SECRETARY5.00Yes (X)Yes (X)$0$0$0
DEREK BAUER
DIRECTOR2.00Yes (X)$0$0$0
FRANCES BRIONES
DIRECTOR2.00Yes (X)$0$0$0
JULIE BLUM
DIRECTOR2.00Yes (X)$0$0$0
MATT BOLGER
DIRECTOR2.00Yes (X)$0$0$0
CHIP BURKHALTER
DIRECTOR2.00Yes (X)$0$0$0
LISA CARLTON
DIRECTOR2.00Yes (X)$0$0$0
MARK CARROLL
DIRECTOR2.00Yes (X)$0$0$0
JULIAN GANGOLLI
DIRECTOR2.00Yes (X)$0$0$0
TANJALA GIPSON
DIRECTOR2.00Yes (X)$0$0$0
JONATHAN GOLDSTEIN
DIRECTOR2.00Yes (X)$0$0$0
STEVEN GOLDSTEIN
DIRECTOR2.00Yes (X)$0$0$0
SHAFALI JESTE
DIRECTOR2.00Yes (X)$0$0$0
JESSICA KREFTING
DIRECTOR2.00Yes (X)$0$0$0
DARCY KRUEGER
DIRECTOR2.00Yes (X)$0$0$0
PATROSKI LAWSON
DIRECTOR2.00Yes (X)$0$0$0
KRISTI LENGYEL
DIRECTOR2.00Yes (X)$0$0$0
HEATHER LENS
DIRECTOR2.00Yes (X)$0$0$0
LAURA MARKS
DIRECTOR2.00Yes (X)$0$0$0
MUSTAFA SAHIN
DIRECTOR2.00Yes (X)$0$0$0
SEAN SHILLINGER
DIRECTOR2.00Yes (X)$0$0$0
ANDREW SPERLING
DIRECTOR2.00Yes (X)$0$0$0
MARK SPOTTS
DIRECTOR2.00Yes (X)$0$0$0
VANESSA VAZQUEZ
DIRECTOR2.00Yes (X)$0$0$0
KARI LUTHER ROSBECK
PRESIDENT & CEO54.00Yes (X)$229,751$2,321$29,8221.00
CYNTHIA ARCURI
CHIEF FINANCIAL OFFICER45.00Yes (X)$184,176$9,693$8,0331.00
STEVEN ROBERDS
CHIEF SCIENTIFIC OFFICER45.00$243,817$0$28,877Yes (X)
DEAN RAGER-AGUIAR
VICE PRESIDENT, TRANSLATIO45.00$183,132$0$31,118Yes (X)
LISA MOSS
VICE PRESIDENT, DONOR RELA45.00$129,161$0$26,747Yes (X)
JAYE ISHAM
CHIEF OUTREACH OFFICER45.00$154,028$0$5,930Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$1,124,065TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$12,014TotReportableCompRltdOrgAmt
Total Other Compensation$130,527TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K6IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (3 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
PSYCHOGENICS INC
20 GRAMERCY PARK SOUTHNEW YORKNY10003RESEARCH LAB SERVICES$2,196,755
VAN ANDEL RESEARCH INSTITUTE
333 BOSTWICK AVE NEGRAND RAPIDSMI49503RESEARCH LAB SERVICES$275,408
CAVAROCCHI RUSCIO DENNIS & ASSOCIATES
600 MARYLAND AVE SW SUITE 220 EASTWASHINGTONDC20024GOVERNMENT RELATIONS$121,737
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K3CntrctRcvdGreaterThan100KCnt
Federated Campaigns$31,703FederatedCampaignsAmt
Membership Dues$600MembershipDuesAmt
Fundraising$2,545,477FundraisingAmt
Related Organizations$239,000RelatedOrganizationsAmt
All Other Contributions$4,231,554AllOtherContributionsAmt
Noncash Contributions$313,610NoncashContributionsAmt
Total Contributions$7,048,334TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtExclusionExclusionAmt
CONTRACT REVENUE900099$2,098,994$2,098,994
CONFERENCE REVENUE900099$6,035$6,035
FieldValueIRS element (for citing)
Total Program Service Revenue$2,105,029TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$48,323TotalRevenueColumnAmt
Exclusion$48,323ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$1,484,318SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$1,479,832SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$4,486SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$4,486TotalRevenueColumnAmt
Exclusion$4,486ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$379,883FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$2,545,477ContriRptFundraisingEventAmt
Fundraising Direct Expenses$529,326FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$149,443TotalRevenueColumnAmt
Exclusion-$149,443ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescCHANGE IN INTEREST OF AFFILIATEDesc
Business900099BusinessCd
Total Revenue Column$938,684TotalRevenueColumnAmt
Exclusion$938,684ExclusionAmt

Miscellaneous Revenue MiscellaneousRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$5,482TotalRevenueColumnAmt
Exclusion$5,482ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$944,166OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$10,000,895TotalRevenueColumnAmt
Related Or Exempt Func Income$2,098,994RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$853,567ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$594,369TotalAmt
Program Services$594,369ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$136,558TotalAmt
Program Services$136,558ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$724,475TotalAmt
Program Services$452,435ProgramServicesAmt
Management And General$105,121ManagementAndGeneralAmt
Fundraising$166,919FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$1,953,740TotalAmt
Program Services$1,174,594ProgramServicesAmt
Management And General$279,508ManagementAndGeneralAmt
Fundraising$499,638FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$57,523TotalAmt
Program Services$35,779ProgramServicesAmt
Management And General$5,835ManagementAndGeneralAmt
Fundraising$15,909FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$229,969TotalAmt
Program Services$143,107ProgramServicesAmt
Management And General$24,484ManagementAndGeneralAmt
Fundraising$62,378FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$188,177TotalAmt
Program Services$117,170ProgramServicesAmt
Management And General$21,250ManagementAndGeneralAmt
Fundraising$49,757FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$29,766TotalAmt
Program Services$20,071ProgramServicesAmt
Management And General$2,797ManagementAndGeneralAmt
Fundraising$6,898FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$23,775TotalAmt
Program Services$16,031ProgramServicesAmt
Management And General$2,234ManagementAndGeneralAmt
Fundraising$5,510FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$119,856TotalAmt
Program Services$80,816ProgramServicesAmt
Management And General$11,264ManagementAndGeneralAmt
Fundraising$27,776FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$282,498TotalAmt
Program Services$185,960ProgramServicesAmt
Management And General$27,854ManagementAndGeneralAmt
Fundraising$68,684FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$16,311TotalAmt
Program Services$7,480ProgramServicesAmt
Management And General$133ManagementAndGeneralAmt
Fundraising$8,698FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$363,869TotalAmt
Program Services$151,657ProgramServicesAmt
Management And General$14,085ManagementAndGeneralAmt
Fundraising$198,127FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$162,481TotalAmt
Program Services$73,818ProgramServicesAmt
Management And General$17,754ManagementAndGeneralAmt
Fundraising$70,909FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$189,963TotalAmt
Program Services$116,454ProgramServicesAmt
Management And General$20,733ManagementAndGeneralAmt
Fundraising$52,776FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$316,059TotalAmt
Program Services$239,428ProgramServicesAmt
Management And General$8,366ManagementAndGeneralAmt
Fundraising$68,265FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$371,834TotalAmt
Program Services$322,368ProgramServicesAmt
Management And General$32,160ManagementAndGeneralAmt
Fundraising$17,306FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$73,012TotalAmt
Program Services$55,807ProgramServicesAmt
Management And General$4,905ManagementAndGeneralAmt
Fundraising$12,300FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$17,889TotalAmt
Program Services$10,985ProgramServicesAmt
Management And General$5,285ManagementAndGeneralAmt
Fundraising$1,619FundraisingAmt

Other Expenses OtherExpensesGrp (3 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
PRECLINICAL CONSORTIUM$2,287,598$2,287,598
NHD BIOSAMPLE REPOSIT$456,639$456,639
DUES AND SUBSCRIPTIONS$34,570$12,249$12,943$9,378

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$29,087TotalAmt
Program Services$23,331ProgramServicesAmt
Management And General$401ManagementAndGeneralAmt
Fundraising$5,355FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$8,660,018TotalAmt
Program Services$6,714,704ProgramServicesAmt
Management And General$597,112ManagementAndGeneralAmt
Fundraising$1,348,202FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$1,487,710BOYAmt
EOY$3,485,780EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$700,650BOYAmt
EOY$706,764EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$4,306,013BOYAmt
EOY$2,754,156EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$350,534BOYAmt
EOY$119,421EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$283,821BOYAmt
EOY$337,110EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$1,124,880LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$490,322LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$393,961BOYAmt
EOY$634,558EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$1,752,986BOYAmt
EOY$1,298,765EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$6,810,093BOYAmt
EOY$7,918,147EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$16,085,768BOYAmt
EOY$17,254,701EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$813,246BOYAmt
EOY$725,038EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$189,493BOYAmt
EOY$194,359EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$1,085,681BOYAmt
EOY$969,191EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$2,088,420BOYAmt
EOY$1,888,588EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$6,372,958BOYAmt
EOY$7,971,055EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$7,624,390BOYAmt
EOY$7,395,058EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$13,997,348BOYAmt
EOY$15,366,113EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$16,085,768BOYAmt
EOY$17,254,701EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$1,340,877ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$27,888NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Info In Schedule O Part XIIYes (X)InfoInScheduleOPartXIIInd
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$4,345,011CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,769,053CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$7,016,851CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$6,496,698CurrentTaxYearMinus1YearAmt
Current Tax Year$6,734,724CurrentTaxYearAmt
Total$30,362,337TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$4,345,011CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,769,053CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$7,016,851CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$6,496,698CurrentTaxYearMinus1YearAmt
Current Tax Year$6,734,724CurrentTaxYearAmt
Total$30,362,337TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$5,015,227SubstantialContributorsTotAmt
Public Support Total170$25,347,110PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$11,188CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$3,809CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$2,382CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$36,732CurrentTaxYearMinus1YearAmt
Current Tax Year$52,809CurrentTaxYearAmt
Total$106,920TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus2 Years$15,492CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$995CurrentTaxYearMinus1YearAmt
Current Tax Year$5,482CurrentTaxYearAmt
Total$21,969TotalAmt
FieldValueIRS element (for citing)
Total Support$30,491,226TotalSupportAmt
Gross Receipts Rltd Activities$11,955,636GrossReceiptsRltdActivitiesAmt
Public Support CY1700.83130PublicSupportCY170Pct
Public Support PY1700.83480PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$4,886FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$234,707FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$239,593FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$7,086,111FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$7,325,704FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$516,285FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$129,071FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$497,465CurrentYearMinus3Amt
Current Year Minus2$550,968CurrentYearMinus2Amt
Current Year Minus1$515,868CurrentYearMinus1Amt
Current Year$516,285CurrentYearAmt
Total$2,080,586TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$3,120,879LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$154,139CurrentYearMinus3Amt
Current Year Minus2$162,771CurrentYearMinus2Amt
Current Year Minus1$188,741CurrentYearMinus1Amt
Current Year$239,593CurrentYearAmt
Total$745,244TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$124,366CurrentYearMinus3Amt
Current Year Minus2$137,742CurrentYearMinus2Amt
Current Year Minus1$128,967CurrentYearMinus1Amt
Current Year$129,071CurrentYearAmt
Total$520,146TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$780,219GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$1,127CurrentYearMinus3Amt
Current Year Minus2$1,395CurrentYearMinus2Amt
Current Year Minus1$1,345CurrentYearMinus1Amt
Current Year$4,886CurrentYearAmt
Total$8,753TotalAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$5,821,187BeginningYearBalanceAmt
Contributions$554,586ContributionsAmt
Investment Earnings Or Losses$671,714InvestmentEarningsOrLossesAmt
Other Expenditures$239,000OtherExpendituresAmt
Administrative Expenses$48,616AdministrativeExpensesAmt
End Year Balance$6,759,871EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$5,500,387BeginningYearBalanceAmt
Contributions$141,816ContributionsAmt
Investment Earnings Or Losses$812,509InvestmentEarningsOrLossesAmt
Other Expenditures$572,625OtherExpendituresAmt
Administrative Expenses$60,900AdministrativeExpensesAmt
End Year Balance$5,821,187EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$6,711,748BeginningYearBalanceAmt
Contributions$68,423ContributionsAmt
Investment Earnings Or Losses-$860,036InvestmentEarningsOrLossesAmt
Other Expenditures$238,000OtherExpendituresAmt
Administrative Expenses$181,748AdministrativeExpensesAmt
End Year Balance$5,500,387EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$5,893,521BeginningYearBalanceAmt
Contributions$132,476ContributionsAmt
Investment Earnings Or Losses$1,053,588InvestmentEarningsOrLossesAmt
Other Expenditures$333,813OtherExpendituresAmt
Administrative Expenses$34,024AdministrativeExpensesAmt
End Year Balance$6,711,748EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$5,915,805BeginningYearBalanceAmt
Contributions$54,645ContributionsAmt
Investment Earnings Or Losses$416,431InvestmentEarningsOrLossesAmt
Other Expenditures$463,721OtherExpendituresAmt
Administrative Expenses$29,639AdministrativeExpensesAmt
End Year Balance$5,893,521EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.84870BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.14580PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.00550TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org0EndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgYes (1)EndowmentsHeldRelatedOrgInd
Related Org List Sch RYes (1)RelatedOrgListSchRInd

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$449,272OtherCostOrOtherBasisAmt
Depreciation$194,003DepreciationAmt
Book Value$255,269BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$595,336OtherCostOrOtherBasisAmt
Depreciation$216,047DepreciationAmt
Book Value$379,289BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$80,272OtherCostOrOtherBasisAmt
Depreciation$80,272DepreciationAmt
Book Value$0BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$634,558TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (3 entries)

DescDescBook ValueBookValueAmt
NET ASSETS OF AFFILIATE$6,759,871
OPERATING LEASE RIGHT-OF-USE ASSET$584,651
DUE FROM AFFILIATE$573,625
FieldValueIRS element (for citing)
Total Book Value Other Assets$7,918,147TotalBookValueOtherAssetsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
OPERATING LEASE LIABILITY$970,571
DUE FROM RELATED PARTY-$1,380
FieldValueIRS element (for citing)
Total Liability$969,191TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$10,052,325TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$27,888NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$23,542DonatedServicesAndUseFcltsAmt
Revenue Not Reported$51,430RevenueNotReportedAmt
Revenue Subtotal$10,000,895RevenueSubtotalAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$10,000,895TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$8,683,560TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$23,542DonatedServicesUseFcltsAmt
Expenses Not Reported$23,542ExpensesNotReportedAmt
Expenses Subtotal$8,660,018ExpensesSubtotalAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$8,660,018TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART V, LINE 4:FormAndLineReferenceDesc
ExplanationTHE ALLIANCE'S ENDOWMENTS CONSIST OF TWO FUNDS ESTABLISHED FOR DIFFERENT PURPOSES. THE ALLIANCE'S ENDOWMENTS INCLUDE ONE TRADITIONAL DONOR-RESTRICTED ENDOWMENT FUND AND ONE BOARD-DESIGNATED ENDOWMENT FUND. THE BOARD-DESIGNATED ENDOWMENT FUND SOLELY CONSISTS OF THE ENDOWMENT FUND'S UNRESTRICTED NET ASSET BALANCE.ExplanationTxt

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (2 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
EUROPE (INCLUDING ICELAND AND GREENLAND)20GRANTS TO RECIPIENTS LOCATED IN THE REGION$131,250
SOUTH ASIA10GRANTS TO RECIPIENTS LOCATED IN THE REGION$5,308
FieldValueIRS element (for citing)
Subtotal Offices3SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office3TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$136,558SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$136,558TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (3 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxtNon Cash AssistanceNonCashAssistanceAmt
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUMRESEARCH ON TUBEROUS SCLEROSIS COMPLEX$75,000WIRE TRANSFER$0
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUMRESEARCH ON TUBEROUS SCLEROSIS COMPLEX$56,250WIRE TRANSFER$0
SOUTH ASIATO COVER COSTS OF CLOSING THE TSC GLOBAL ALLIANCE$5,308WIRE TRANSFER$0
FieldValueIRS element (for citing)
Total Other Org3TotalOtherOrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationGRANTEE ORGANIZATIONS ARE EXPECTED TO FILE ANNUAL PROGRESS REPORTS TO OUTLINED GRANT GOALS AND MILESTONES. THESE REPORTS ARE REVIEWED BY A COMMITTEE OF PEERS. THIS COMMITTEE MAKES DETERMINATIONS BASED ON QUALITY OF WORK TO GOALS AND IF THE GRANTEE WILL CONTINUE TO RECEIVE FUNDING. A FINAL WRITTEN AND FINANCIAL REPORT IS REQUIRED OF ALL GRANTEES.ExplanationTxt

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1STEP FORWARD TO CURE TSCEvent1Nm
Gross Receipts Event1$781,985GrossReceiptsEvent1Amt
Charitable Contri Event1$781,985CharitableContriEvent1Amt
Non Cash Prizes Event1$21,874NonCashPrizesEvent1Amt
Rent Facility Costs Event1$7,438RentFacilityCostsEvent1Amt
Food And Beverage Event1$11,301FoodAndBeverageEvent1Amt
Entertainment Event1$8,952EntertainmentEvent1Amt
Event250TH ANNIVERSARY GALAEvent2Nm
Gross Receipts Event2$1,525,220GrossReceiptsEvent2Amt
Charitable Contri Event2$1,231,266CharitableContriEvent2Amt
Gross Revenue Event2$293,954GrossRevenueEvent2Amt
Non Cash Prizes Event2$30,000NonCashPrizesEvent2Amt
Rent Facility Costs Event2$131,920RentFacilityCostsEvent2Amt
Food And Beverage Event2$188,715FoodAndBeverageEvent2Amt
Other Events Total8OtherEventsTotalCnt
Gross Receipts Other Events$618,155GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$532,226CharitableContriOtherEventsAmt
Gross Revenue Other Events$85,929GrossRevenueOtherEventsAmt
Non Cash Prizes Other Events$5,672NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events$57,174RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events$65,163FoodAndBeverageOtherEventsAmt
Entertainment Other Events$1,117EntertainmentOtherEventsAmt
Gross Receipts Total$2,925,360GrossReceiptsTotalAmt
Charitable Contributions Tot$2,545,477CharitableContributionsTotAmt
Gross Revenue Total Events$379,883GrossRevenueTotalEventsAmt
Non Cash Prizes Total Events$57,546NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events$196,532RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$265,179FoodAndBeverageTotalEventsAmt
Entertainment Total Events$10,069EntertainmentTotalEventsAmt
Direct Expense Summary Events$529,326DirectExpenseSummaryEventsAmt
Net Income Summary-$149,443NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (9 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
BAYLOR COLLEGE OF MEDICINE
PO BOX 301207DALLASTX70690741613878501(C)(3)$75,000$0RESEARCH GRANT
EMORY UNIVERSITY
PO BOX 935084ATLANTAGA31193580566256501(C)(3)$18,750$0RESEARCH GRANT
NORTHWESTERN UNIVERSITY
633 CLARK ST ROOM G547EVANSTONIL60208362167817501(C)(3)$18,750$0RESEARCH GRANT
COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
615 W 131ST STREET 6TH FLOOR MAILNEW YORKNY10027135598093501(C)(3)$56,250$0RESEARCH GRANTCODE 8725
UNIVERSITY OF CALIFORNIA IRVINE
228 ALDRICH HALLIRVINECA92697952226406501(C)(3)$75,000$0RESEARCH GRANT
UNIVERSITY OF MASSACHUSETTS
55 LAKE AVENUE NORTH SUITE S1-859WORCESTERMA01655542084125501(C)(3)$18,750$0RESEARCH GRANT
UNIVERSITY OF TEXAS DALLAS
800 WEST CAMPBEL ROAD SP2 27RICHARDSONTX75080751305566501(C)(3)$75,000$0RESEARCH GRANT
NATIONAL ORGANIZATION FOR RARE DISORDERS
DEPT 5430 PO BOX 4110WOBURNMA01888133223946501(C)(3)$175,000$0TSC TRAVEL AND LODGING ASSISTANCE PROGRAM
BOSTON CHILDREN'S HOSPITAL
PO BOX 414413BOSTONMA02241042774441501(C)(3)$81,869$0RESEARCH GRANT
FieldValueIRS element (for citing)
Total501c3 Org9Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationTHE TSC ALLIANCE HAS FUNDED $39 MILLION IN RESEARCH ON TSC SINCE 1984. DIRECTED BY STEVEN L. ROBERDS, PH.D, CHIEF SCIENTIFIC OFFICER, THE TSC ALLIANCE RESEARCH GRANTS PROGRAM FUNDS RESEARCH FOCUSED ON TSC WITH PRIORITIES SET BY THE RESEARCHERS TOGETHER WITH THE TSC ALLIANCE. COLLABORATIONS BETWEEN BASIC AND CLINICAL RESEARCHERS ARE ENCOURAGED AND FOSTERED, AND THE TSC ALLIANCE IS WORKING TO INCREASE FUNDING FOR RESEARCH ON TSC. THROUGH THE TSC ALLIANCE RESEARCH GRANTS PROGRAM, APPLICATIONS CAN BE SUBMITTED FOR POSTDOCTORAL FELLOWSHIPS AND TSC RESEARCH GRANTS. GRANTS ARE REVIEWED IN A THREE-STEP PROCESS: 1. A GRANT REVIEW COMMITTEE COMPOSED OF INDIVIDUALS KNOWLEDGEABLE ABOUT THE CLINICAL AND BASIC COMPONENTS OF TSC AS WELL AS CONSUMERS REVIEW ALL GRANT APPLICATIONS FOR SCIENTIFIC MERITS, RELEVANCY TO THE FUNDING PRIORITIES OF THE ORGANIZATION AND WITH A FOCUS ON UNDERSTANDING THE MECHANISMS OF TSC AND/OR THE DEVELOPMENT OF TREATMENTS AND THERAPIES FOR THE MANIFESTATIONS OF THE DISEASE. 2. THE SCIENCE AND MEDICAL COMMITTEE OF THE BOARD OF DIRECTORS THEN REVIEWS THE GRANT REVIEW COMMITTEE'S CONCLUSIONS AND MAKES FUNDING RECOMMENDATIONS TO THE BOARD OF DIRECTORS. 3. THE BOARD OF DIRECTORS THEN REVIEWS THE RECOMMENDATIONS OF THE SCIENCE AND MEDICAL COMMITTEE AND MAKES FINAL APPROVAL FOR THE FUNDING OF GRANTS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgYes (1)CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgYes (1)CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (6 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
STEVEN ROBERDS
CHIEF SCIENTIFIC OFFICER$221,251$0$22,566$0$0$0$7,509$0$21,368$0$272,694$0$0$0
KARI LUTHER ROSBECK
PRESIDENT & CEO$207,898$2,100$21,853$221$0$0$7,220$0$22,602$0$259,573$2,321$0$0
DEAN RAGER-AGUIAR
VICE PRESIDENT, TRANSLATIO$163,575$0$19,557$0$0$0$5,863$0$25,255$0$214,250$0$0$0
CYNTHIA ARCURI
CHIEF FINANCIAL OFFICER$166,658$8,771$17,518$922$0$0$5,814$0$2,219$0$192,209$9,693$0$0
JAYE ISHAM
CHIEF OUTREACH OFFICER$140,182$0$13,846$0$0$0$4,609$0$1,321$0$159,958$0$0$0
LISA MOSS
VICE PRESIDENT, DONOR RELA$116,082$0$13,079$0$0$0$4,178$0$22,569$0$155,908$0$0$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 5KARI LUTHER ROSBECK, STEVE ROBERDS, CYNTHIA ARCURI, DEAN AGUIAR, JAYE ISHAM, AND LISA MOSS, ALL HAVE INCENTIVE COMPENSATION EQUAL TO A PERCENTAGE OF THEIR SALARIES BASED ON KEY PERFORMANCE OBJECTIVES AS ESTABLISHED BY THEIR COMPENSATION COMMITTEE.
PART I, LINE 6KARI LUTHER ROSBECK, STEVE ROBERDS, CYNTHIA ARCURI, DEAN AGUIAR, JAYE ISHAM, AND LISA MOSS ALL HAVE INCENTIVE COMPENSATION EQUAL TO A PERCENTAGE OF THEIR SALARIES BASED ON KEY PERFORMANCE OBJECTIVES AS ESTABLISHED BY THEIR COMPENSATION COMMITTEE.

Schedule M IRS990ScheduleM

Other Non Cash Contri Table OtherNonCashContriTableGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
DescMEDICAL EQUIPMENTSDesc
Contribution4ContributionCnt
Noncash Contributions Rpt F990$313,610NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts0ReviewProcessUnusualNCGiftsInd
Third Parties Used0ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, COLUMN (B):FormAndLineReferenceDesc
ExplanationAMOUNT REPORTED IS THE NUMBER OF ITEMS CONTRIBUTED.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (10 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE:THERE IS NATURAL TURNOVER OF INDUSTRY MEMBERSHIP, PRINCIPALLY DRIVEN BY RESEARCH DATA GENERATED BY TESTING THEIR DRUGS. DUE TO INTELLECTUAL PROPERTY CONSIDERATIONS, MOST COMPANIES FULLY FUND THEIR STUDIES THROUGH THE TSC ALLIANCE, WHICH ALLOWS THE COMPANY TO KEEP ITS DATA CONFIDENTIAL. THESE CONFIDENTIAL STUDIES ALSO INCUR A 10% OVERHEAD PAID BY THE COMPANY, WHICH IS A SOURCE OF REVENUE FOR THE TSC ALLIANCE. THE CONSORTIUM TESTED NINE UNIQUE COMPOUNDS IN 2024, RAISING THE TOTAL TESTED TO 91 SINCE 2016. MANY COMPOUNDS WILL ENTER PRECLINICAL TESTING, THOUGH ONLY SOME WILL ADVANCE TO CLINICAL TESTING DUE TO LACK OF EFFICACY AND SAFETY. IN 2012, THE TSC ALLIANCE HELPED CREATE THE TSC CLINICAL RESEARCH CONSORTIUM IN PARTNERSHIP WITH INVESTIGATORS RUNNING CLINICAL STUDIES TO ENSURE CLINICAL RESEARCH IN TSC IS AS EFFICIENT AND EFFECTIVE AS POSSIBLE. SINCE THEN, TSC CLINICAL RESEARCH CONSORTIUM INVESTIGATORS HAVE BEEN AWARDED MORE THAN $40 MILLION BY THE NATIONAL INSTITUTES OF HEALTH (NIH) AND FOOD AND DRUG ADMINISTRATION (FDA) THROUGH COMPETITIVE GRANT PROCESSES. TSC ALLIANCE PERSONNEL SERVE ON THE LEADERSHIP TEAM FOR THE CONSORTIUM, ACTIVELY TRACK ENROLLMENT, AND RAISE COMMUNITY AWARENESS TO HELP IDENTIFY POTENTIAL PARTICIPANTS FOR CLINICAL STUDIES. TSC ALLIANCE ALSO PROVIDES SUPPLEMENTAL FINANCIAL SUPPORT TO ACCELERATE OR EXPAND NIH-FUNDED STUDIES. IN 2020, THE TSC ALLIANCE PROVIDED $200,000 SUPPLEMENTAL FUNDING FOR TSC-STEPS (STOPPING TSC ONSET AND PROGRESSION 2B: SIROLIMUS TSC EPILEPSY PREVENTION STUDY), WHICH IS ONGOING. THE TSC ALLIANCE CONTINUES TO EDUCATE THE COMMUNITY ABOUT THIS PIVOTAL TRIAL. TWENTY-EIGHT INFANTS HAVE BEEN ENROLLED TO DATE AND TWENTY-THREE BIOSPECIMENS COLLECTED. THE TSC ALLIANCE IS ALSO PROVIDING SUPPLEMENTAL FUNDING AND COLLECTING BLOOD SAMPLES FOR THE DEVELOPMENTAL SYNAPTOPATHIES CONSORTIUM (DSC), AN NIH-FUNDED PROJECT THAT INCLUDES STUDIES OF TSC AND THE RELATED RARE DISORDERS PHELAN-MCDERMID SYNDROME AND PTEN HAMARTOMA SYNDROME. THESE THREE RARE DISEASES SEEM TO AFFECT CERTAIN SHARED PATHWAYS INFLUENCING THE DEVELOPMENT OF BRAIN CONNECTIONS, OR SYNAPSES. RESEARCHERS IN THIS STUDY ARE TRYING TO FIND EARLIER SIGNS OF AUTISM SPECTRUM DISORDER (ASD) AND INTELLECTUAL DISABILITY (ID) TO GAIN A BETTER UNDERSTANDING OF ASD/ID IN INDIVIDUALS WITH TSC AND ENABLE EFFECTIVE TREATMENTS AND INTERVENTIONS FOR ASD/ID TO BE FOUND. THE DSC WAS RENEWED IN 2019 FOR A SECOND 5-YEAR FUNDING PERIOD. THE TSC ALLIANCE FUNDS A PORTION OF CLINICAL RESEARCH COORDINATORS' SALARIES AT 5 SITES. IN 2024, THE TSC ALLIANCE AWARDED AN ADDITIONAL 12 MONTHS OF FUNDING, $163,737 IN TOTAL, TO SUPPORT COLLECTION OF ADDITIONAL DATA AND BIOSAMPLES FROM AUGUST 2024 THROUGH JULY 2025. THANKS TO A GIFT FROM THE RAMESH AND KALPANA BHATIA FAMILY FOUNDATION, THE TSC ALLIANCE CREATED ANYA'S ACCELERATOR TO FOCUS ON FURTHERING TRANSLATIONAL RESEARCH ON TAND. THE TSC ALLIANCE HOSTED AN INNOVATION WORKSHOP IN APRIL 2023, WHICH FOCUSED ON IDENTIFYING BIOMARKERS AND PREDICTORS OF SPECIFIC ASPECTS OF TAND THROUGH COLLABORATIVE AND INCLUSIVE ANALYSIS OF EXISTING BIOSAMPLES AND DATA VIA METABOLOMIC, GENETIC (RNA-SEQ), OR OTHER METHODS. AFTER THIS INNOVATIVE WORKSHOP, WE BEGAN PLOTTING A COURSE TO IDENTIFY FLUID-BASED BIOMARKERS TO IMPROVE CLINICAL TRIALS AND CLINICAL CARE ASSOCIATED WITH TAND. IN 2024 WE COMPLETED ANALYSIS OF 84 SAMPLES FROM THE DSC PROJECT UTILIZING PROTEIN ANALYSIS USING AN 11K PROTEIN ASSAY AT SOMALOGIC AND WHOLE GENOME SEQUENCING. IN 2024 THE TSC ALLIANCE APPROVED A PROPOSAL TO BEGIN IN 2025 THE ANYA'S ACCELERATOR PATIENT-REPORTED OUTCOME MEASURE (PROM) PROJECT, LED IN COLLABORATION WITH AGNIES VAN EEGHEN, MD, PHD OF UMC AMSTERDAM. HER PROJECT WILL FOCUS ON THE HARMONIZATION OF PRO MEASURES USED BOTH IN STANDARD OF CARE AND CLINICAL TRIALS TO STANDARDIZE THE ASSESSMENT OF SYMPTOMS UNDER THE TAND UMBRELLA. IN MARCH 2024, THE TSC ALLIANCE HOSTED A REPRODUCTIVE AND PERINATAL HEALTH (RPH) WORKSHOP IN MEMPHIS, TENNESSEE. THE WORKSHOP GATHERED MORE THAN 25 TSC AND LAM EXPERTS AND STAKEHOLDERS TO DISCUSS PRESENT AND FUTURE CLINICAL RECOMMENDATIONS FOR WOMEN WITH TSC AND/OR LAM WHO BECOME PREGNANT. OUTCOMES INCLUDED: THE DEVELOPMENT OF A SURVEY TO GATHER COMMUNITY PERSPECTIVES ON PREGNANCY AND TSC, DRAFTING A CALL-TO-ACTION AND RISK STRATIFICATION MANUSCRIPT TO BE SUBMITTED FOR PUBLICATION, AND IDENTIFYING POTENTIAL COLLABORATORS WITH EXISTING PREGNANCY DATABASES TO GATHER MORE CLINICAL EVIDENCE TOWARDS ESTABLISHING CLINICAL GUIDELINES.
FORM 990, PART III, LINE 4B, DESCRIPTION OF PROGRAM SERVICE:SUPPORT SERVICES IS DEDICATED TO SUPPORTING INDIVIDUALS AND FAMILIES AFFECTED BY TSC THROUGH OUTREACH PROGRAMS, SUPPORT SERVICES, IMPROVED MEDICAL ACCESS, AND EDUCATIONAL RESOURCES. IN 2024, THE TSC ALLIANCE FULLY IMPLEMENTED A NEW COMMUNITY SUPPORT MODEL THAT PUTS THE TSC COMMUNITY CENTER FOCUSING ON LOCAL RESOURCES, SUPPORT SERVICES, AND ACCESS TO MEDICAL CARE IN CONJUNCTION WITH ENERGIZING THE CURRENT AND FUTURE VOLUNTEER LEADERS TO PROPEL THE TSC ALLIANCE TO THE NEXT LEVEL. THIS MODEL UNITED 36 COMMUNITY ALLIANCES AND ORGANIZED THEM INTO 14 COMMUNITY REGIONS, LED BY MORE THAN 138 DEDICATED LEADERS THROUGHOUT THE UNITED STATES. THE COMMUNITY PROGRAMS TEAM INVESTED MORE THAN 997 TRAINING HOURS TO OUR LEADERS, TO ENSURE THEY WERE WELL EQUIPPED TO SUPPORT AND EMPOWER THE TSC COMMUNITY. AS A RESULT, WE PROVIDED 3,473 PEER-TO-PEER SUPPORT ENGAGEMENTS AND FACILITATED 88 SCHOOL MEETINGS, WHICH INVOLVED TSC 101 TRAINING AND IEP CONSULTATIONS. IN ADDITION, FIVE "ASK AN ADVOCATE" WEBINARS ATTRACTED 609 REGISTRANTS. THE COMMUNITY PROGRAMS TEAM COLLABORATED WITH KEY STAFF TO HOST TWO RESEARCH AND CORPORATE PARTNER WEBINARS. THESE WEBINARS ATTRACTED 142 LIVE ATTENDEES AND GARNERED 267 RECORDED VIEWS AS OF DECEMBER 31, 2024. THE TSC ALLIANCE HOSTED TWO EDUCATIONAL REGIONAL TSC CONFERENCES HELD IN CHAPEL HILL, NC AND PALO ALTO, CA AND TWO TRANSITION WORKSHOPS IN MEMPHIS, TN AND SALT LAKE CITY, UT. THESE CONFERENCES ATTRACTED 245 PARTICIPANTS. THE TSC ALLIANCE'S TSC NAVIGATOR IS AN EASY-TO-USE, INTERACTIVE ONLINE TOOL TO HELP GUIDE INDIVIDUALS AND FAMILIES THROUGH THE COMPLEXITIES OF TSC ACROSS THE LIFESPAN, PROACTIVELY MANAGE THEIR CARE, AND LIVE THEIR FULLEST LIVES. USERS CAN ACCESS INFORMATION BASED ON THE AGE OF ONE'S DIAGNOSIS, SUCH AS PRENATAL, CHILDHOOD, OR ADULT, TO HELP DETERMINE WHICH STEPS WILL HELP EMPOWER THEM THROUGHOUT THEIR INDIVIDUAL JOURNEYS. IN 2024, AS PART OF THE TSC ALLIANCE'S WEBSITE REDESIGN, TSC NAVIGATOR WAS EXPANDED ACROSS MORE PAGES ON THE WEBSITE. TSC NAVIGATOR CONTENT HAD 72,249 PAGE VIEWS IN 2024 FROM 37,869 USERS. SUPPORT NAVIGATORS ASSISTED 290 FAMILIES INCLUDING 23 ONE-HOUR LONG SUPPORT NAVIGATOR CALLS. NINE INDIVIDUALS OR FAMILIES WERE ALSO SUPPORTED FOR MEDICATION ACCESS ISSUES VIA OUR TSC NAVIGATOR PROGRAM DURING 2024, UP FROM 5 IN 2023, CONSISTENT WITH THE GOAL OF PROACTIVELY HELPING PEOPLE AVOID MEDICATION ACCESS ISSUES.
FORM 990, PART III, LINE 4C, DESCRIPTION OF PROGRAM SERVICE:PUBLIC HEALTH EDUCATION INCREASES AWARENESS OF TSC THROUGHOUT THE GENERAL PUBLIC TO BROADEN THE SCOPE OF SUPPORT AND UNDERSTANDING BEYOND TSC INDIVIDUALS AND THEIR FAMILIES; THESE EFFORTS ALSO WORK TO HELP REACH THE UNDIAGNOSED AND NEWLY DIAGNOSED. DURING 2024, THE TSC ALLIANCE PRODUCED TWO ISSUES OF ITS NATIONAL MAGAZINE, PERSPECTIVE, WHICH IS MAILED TO APPROXIMATELY 19,000 CONSTITUENTS AS WELL AS POSTED ON THE WEBSITE. THE TSC ALLIANCE'S PODCAST SERIES, CALLED TSC NOW, PRODUCED THREE EPISODES WITH 1,391 TOTAL LISTENS. SIX ISSUES OF THE ELECTRONIC TSC MATTERS NEWSLETTER WERE DISTRIBUTED TO 16,838 RECIPIENTS. IN JANUARY 2024, THE TSC DEBUTED A REDESIGNED WEBSITE FEATURING STREAMLINED NAVIGATION. THE TSC ALLIANCE'S WEBSITE INCREASES AWARENESS AND PROVIDES EXTENSIVE EDUCATION THROUGH A MONTHLY AVERAGE OF 22,641 PAGE VIEWS. THE TSC ALLIANCE ALSO RELIES HEAVILY ON SOCIAL MEDIA TO EDUCATE CONSTITUENTS AND PROMOTE NEW RESOURCES AND EVENTS. ITS PRIVATE FACEBOOK TSC DISCUSSION GROUP BOASTS MORE THAN 11,172 MEMBERS FROM AROUND THE WORLD, WHILE ITS X ACCOUNT HAS 2,659 FOLLOWERS, LINKEDIN HAS 2,453 FOLLOWERS AND INSTAGRAM HAS 3,921 FOLLOWERS. TO INCREASE PUBLIC AWARENESS, THE TSC ALLIANCE PARTICIPATED IN THE 12TH ANNUAL TSC GLOBAL AWARENESS DAY ON MAY 15 AS WELL AS TSC AWARENESS MONTH THROUGHOUT MAY. THE TSC ALLIANCE ALSO HEAVILY PROMOTED INFANTILE SPASMS AWARENESS WEEK (DECEMBER 1 TO 7). THESE AWARENESS CAMPAIGNS ALONG WITH THE ORGANIZATION'S VARIOUS NEWS RELEASES AND SOCIAL MEDIA OUTREACH EFFORTS CULMINATED IN MORE THAN 1.1 BILLION CUMULATIVE IMPRESSIONS AND ENGAGEMENTS.
FORM 990, PART VI, SECTION A, LINE 6MEMBERSHIP IN THE CORPORATION IS AVAILABLE TO ANY PERSON WHO SUBSCRIBES TO THE PURPOSES AND OBJECTIVES OF THE CORPORATION, WITHOUT REGARD TO RACE, RELIGION, GENDER, SEXUAL ORIENTATION, AGE, COLOR, NATIONAL ORIGIN, OR MENTAL OR PHYSICAL HANDICAP OR DISABILITY. THERE IS NO LIMIT TO THE NUMBER OF MEMBERS IN THE CORPORATION. 1) THERE MAY BE ONE OR MORE CLASSES OF MEMBERSHIP AS DETERMINED BY THE BOARD. 2) MEMBERSHIP IS NOT TRANSFERABLE OR ASSIGNABLE.
FORM 990, PART VI, SECTION A, LINE 7ATHE TSC ALLIANCE IS A MEMBERSHIP-BASED ORGANIZATION, WHICH MEANS MEMBERS HELP ELECT THE BOARD OF DIRECTORS. THE TSC ALLIANCE MEMBERSHIP PROGRAM ALLOWS INDIVIDUALS TO STATE THEIR INTENT TO BE A MEMBER FOR THE PURPOSE OF GOVERNANCE. THERE WERE NO LEVELS TO MEMBERSHIP IN 2024. ANYONE CAN BE A MEMBER AT NO COST.
FORM 990, PART VI, SECTION B, LINE 11BTHE FORM 990 IS REVIEWED, IN DETAIL, BY THE BOARD OF DIRECTORS' AUDIT COMMITTEE. RECOMMENDATIONS ARE MADE BY THE COMMITTEE MEMBERS FOR ANY CHANGES/EDITS/ADDITIONS. AFTER THOSE HAVE BEEN INCORPORATED, THE AUDIT COMMITTEE VOTES WHETHER TO APPROVE AND THEN FORWARD THE 990 TO THE FINANCE AND EXECUTIVE COMMITTEES. THE FINANCE AND EXECUTIVE COMMITTEES PERFORM THE FINAL REVIEW AND THEN VOTE WHETHER TO APPROVE ON BEHALF OF THE BOARD OF DIRECTORS. A COPY OF THE APPROVED 990 IS SHARED WITH THE ENTIRE BOARD PRIOR TO ITS FILING WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12C"ANNUALLY EACH MEMBER OF THE BOARD OF DIRECTORS WILL RECEIVE NOTICE OF THE ORGANIZATION'S CONFLICT OF INTEREST STATEMENT. EACH MEMBER WILL BE PROVIDED WITH A STATEMENT TO MAKE DISCLOSURE OF ANY POTENTIAL CONFLICT OF INTEREST. IF DURING THE COURSE OF THE YEAR A POTENTIAL CONFLICT OF INTEREST ARISES THAT HAS NOT PREVIOUSLY BEEN DISCLOSED, THE BOARD MEMBER WILL MAKE WRITTEN NOTICE OF A POTENTIAL CONFLICT OF INTEREST AND RECUSE HIMSELF OR HERSELF FROM ANY DISCUSSIONS AND VOTES IN CONNECTION WITH THE ISSUE IDENTIFIED. ANY TIME A MEMBER IS RECUSED FROM DISCUSSION ON AN ISSUE, THE MINUTES OF COMMITTEE MEETING AND BOARD MEETING WILL DULY RECORD SUCH ACTIONS." THE FOLLOWING POTENTIAL CONFLICTS OF INTEREST WERE DISCLOSED FOR 2024: BOARD MEMBER MUSTAFA SAHIN, PH.D., M.D., IS EMPLOYED AT BOSTON CHILDREN'S HOSPITAL, WHICH RECEIVED $81,869 IN GRANTS AND $9,340 IN FEES FOR SERVICES,FOR PARTICIPATION IN THE TSC NATURAL HISTORY DATABASE. BOARD MEMBER DARCY KRUEGER, MD, MPA, IS EMPLOYED AT THE CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER, WHICH RECEIVED $4,255 IN FEES FOR SERVICES FOR PARTICIPATION IN THE TSC NATURAL HISTORY DATABASE. BOARD MEMBER JESSICA KREFTING, RN, IS EMPLOYED AT UNIVERSITY OF ALABAMA AT BIRMINGHAM, WHICH $7,765 IN FEES FOR SERVICES FOR PARTICIPATION IN THE TSC NATURAL HISTORY DATABASE.
FORM 990, PART VI, SECTION B, LINE 15"THE COMPENSATION COMMITTEE REVIEWS AND APPROVES THE SALARIES OF THE PRESIDENT/CEO, CHIEF SCIENTIFIC OFFICER, CFO, AND ANY EMPLOYEE APPEARING ON THE FORM 990, IN ACCORDANCE WITH THE TSC ALLIANCE BYLAWS. SUCH REVIEW AND APPROVAL OCCURS INITIALLY UPON HIRING, UPON ANNUAL REVIEWS, AND WHENEVER MODIFIED. THE ORGANIZATION'S EXECUTIVE REMUNERATION HAS BEEN STRUCTURED TO ENSURE THAT IT: IS REASONABLE; PROVIDES A COMPETITIVE COMPENSATION PROGRAM TO RETAIN, ATTRACT AND REWARD KEY EMPLOYEES AND ACHIEVES CLEAR ALIGNMENT BETWEEN TOTAL REMUNERATION AND DELIVERED BUSINESS AND PERSONAL PERFORMANCE OVER THE SHORT AND LONG-TERMS. THE COMPENSATION IS REVIEWED BY THE COMPENSATION COMMITTEE TO ENSURE: - COMPARABILITY, - PROPER REVIEW, AND - SUBSTANTIATION IN SETTING THE COMPENSATION."
FORM 990, PART VI, SECTION C, LINE 19ALL GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON WRITTEN REQUEST.
FORM 990, PART XII, LINE 2C:THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1TSC ALLIANCE ENDOWMENT FUND INCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line18737 COLESVILLE ROAD NO 400AddressLine1Txt
CitySILVER SPRINGCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd
FieldValueIRS element (for citing)
EIN521926919EIN
Primary ActivitiesSUPPORT THE MISSION OF THE TSC ALLIANCEPrimaryActivitiesTxt
Legal Domicile StateMDLegalDomicileStateCd
Exempt Code Section501(C)(3)ExemptCodeSectionTxt
Public Charity StatusLINE 12B, IIPublicCharityStatusTxt
Direct Controlling NAN/ADirectControllingNACd
Controlled Organization0ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org0GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgYes (1)GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (1)SharingOfFacilitiesInd
Paid Employees SharingYes (1)PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp

Other Organization Name OtherOrganizationName

FieldValueIRS element (for citing)
Business Name Line1TSC ALLIANCE ENDOWMENT FUND INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Transaction TypeCTransactionTypeTxt
Involved$239,000InvolvedAmt
Method Of Amount DeterminationACTUAL CASH RECEIVEDMethodOfAmountDeterminationTxt

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.